Lam Research (LRCX)
(Delayed Data from NSDQ)
$888.92 USD
-23.34 (-2.56%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $886.00 -2.92 (-0.33%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Income Statements
Fiscal Year end for Lam Research Corporation falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 17,429 | 17,227 | 14,626 | 10,045 | 9,654 |
Cost Of Goods | 9,652 | 9,355 | 7,821 | 5,436 | 5,295 |
Gross Profit | 7,777 | 7,872 | 6,805 | 4,609 | 4,358 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,602 | 2,490 | 2,323 | 1,935 | 1,894 |
Income After Depreciation & Amortization | 5,175 | 5,382 | 4,482 | 2,674 | 2,465 |
Non-Operating Income | -66 | -189 | -111 | -99 | -18 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 5,109 | 5,193 | 4,371 | 2,575 | 2,447 |
Income Taxes | 598 | 588 | 462 | 323 | 255 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 4,511 | 4,605 | 3,908 | 2,252 | 2,191 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 4,511 | 4,605 | 3,908 | 2,252 | 2,191 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 5,517 | 5,716 | 4,789 | 2,948 | 2,781 |
Depreciation & Amortization (Cash Flow) | 342 | 334 | 307 | 274 | 317 |
Income After Depreciation & Amortization | 5,175 | 5,382 | 4,482 | 2,674 | 2,465 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 135.83 | 140.63 | 145.32 | 149.09 | 159.92 |
Diluted EPS Before Non-Recurring Items | 34.17 | 33.12 | 27.24 | 15.95 | 14.55 |
Diluted Net EPS (GAAP) | 33.21 | 32.75 | 26.90 | 15.10 | 13.70 |
Fiscal Year end for Lam Research Corporation falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 3,758.26 | 3,482.06 | 3,207.26 | 3,869.57 |
Cost Of Goods | NA | 2,000.80 | 1,827.36 | 1,749.13 | 2,263.96 |
Gross Profit | NA | 1,757.46 | 1,654.70 | 1,458.13 | 1,605.61 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 700.24 | 631.67 | 603.52 | 663.36 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,057.22 | 1,023.03 | 854.61 | 942.25 |
Non-Operating Income | NA | 29.84 | 2.60 | 9.01 | -3.33 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 1,087.05 | 1,025.63 | 863.62 | 938.92 |
Income Taxes | NA | 132.79 | 138.23 | 61.08 | 124.91 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 954.27 | 887.40 | 802.54 | 814.01 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 954.27 | 887.40 | 802.54 | 814.01 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 132.22 | 133.17 | 134.39 | 135.40 |
Diluted EPS Before Non-Recurring Items | NA | 7.52 | 6.85 | 5.98 | 6.99 |
Diluted Net EPS (GAAP) | NA | 7.22 | 6.66 | 6.04 | 6.01 |